Aarti Pharmalabs Piyush Lakhani as Chief resigns
Aarti Pharmalabs (NSE: AARTIPHARM) said Piyush Lakhani as Chief has resigned. The company is valued at about ₹7,998 crore.
What happened
Aarti Pharmalabs (NSE: AARTIPHARM) informed the stock exchanges on 28 October 2026 at 09:09 PM that Piyush Lakhani as Chief has resigned.
From the filing: "Aarti Pharmalabs Limited has informed the Exchange regarding Resignation of Shri Piyush Lakhani as Chief Financial Officer of the company He will be relievedfrom the services of the Company with effect from the close of business hours on October 30, 2026."
Company snapshot
Aarti Pharmalabs is a small-cap company in the Healthcare sector, with a market value of about ₹7,998 crore.
The stock last traded at ₹882, against a 52-week range of ₹585–₹1,002.4 (12.0% below the high).
Before this filing the shares had moved −12.4% over the month and +20.3% over three months. Average daily turnover over the last 20 sessions was about ₹51.81 crore.
Promoters held 42.86% at the end of Q1 FY27, down 0.22% points from the previous quarter; 11.08% of promoter shares were pledged. Foreign institutions owned 8.17% and domestic institutions 7.22%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 386 | 49.5 | 5.46 |
| Q2 FY26 | 418 | 28.6 | 3.08 |
| Q3 FY26 | 432 | 46.4 | 5.29 |
| Q4 FY26 | 583 | 61.1 | 6.74 |
| Q1 FY27 | 536 | 76.1 | 8.4 |
What history shows
BCEIE's records show 7 previous management change filings from the company since May 2026.
After those filings, the stock gained 15.7% on average the next trading day and was up 12.7% on average after five days (3 filings with price data).
Across 107 similar disclosures by other Healthcare companies, shares moved +0.3% on average the next day and +1.2% over five days; 47% of them rose the next day.
Market-wide, 4,012 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 7 Aug 2026 | Change in Director(s) of the company. | +28.8% | +25.7% |
| 7 Aug 2026 | Change in Director(s) of the company. | +28.8% | +25.7% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
- 28 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Aarti Pharmalabs revamps website to enhance digital accessibility
- AARTI PHARMALABS LIMITED (AARTIPHARM.NS) Q3 25/26 earnings call transcript
- Aarti Pharmalabs (NSEI:AARTIPHARM) - Stock Analysis
- Aarti Pharmalabs Slips 4.73% to ₹832.35 as Sellers Test the ₹790.73 Support Zone - Virgin POC
- Aarti Pharmalabs Q2 consolidated net profit up 170% to ₹754 crore
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.